The annual costs associated with XXXX types 6, 11, 16, and 18 infections in Finland.

@entity5 @entity1083 @entity1082 @entity66
OBJECTIVES: It is known that infections with @entity1082 ) types 6, 11, 16, and 18, cause @entity5 ( @entity5 ), cervical intraepithelial neoplastic lesions (types 1 to 3; CIN 1-3), and genital warts (GW). Together with equivocal cytological abnormalities (ECA), these place a considerable burden on society, but the costs and resource usage are not easily estimated. Therefore, we undertook this study to estimate the burden and costs associated with @entity66 . METHODS: We used Finnish registry-based data for @entity5 , CIN 1-3 and ECA. Data on GW were estimated from associated procedures and medications. The annual burden of disease was estimated from hospitalizations, visits to specialists and primary level care, and pharmaceutical use. The evaluation of costs included health care and screening costs, and productivity lost (separately). Due to the data obtained being fragmented, 2 cost scenarios were constructed. RESULTS: The follow-up of ECA appears to be the most important cost driver. GW should not be underestimated as they affect both genders at an early age. CONCLUSIONS: @entity1083 are a burden to society, not only as a result of @entity5 , but also costs related to other diseases and indirect costs in the form of lost productivity.
